Longevity & AgingResearch PaperOpen Access

How T Cells Divide May Help Predict Vaccine Responses

Human T cells that divide their recycling machinery unevenly showed better vaccine responses, pointing to a potential route to stronger immune memory.

Thursday, November 12, 2026 0 views
Published in Sci Adv
A researcher examining fluorescently stained dividing T cells on a microscope monitor in an immunology laboratory

Summary

When an activated T cell divides, it can hand its two daughters different cargo, so one becomes a short-lived fighter and the other a long-lived memory cell. Researchers showed that human CD8+ T cells do this and that the cargo includes autophagy machinery (the cell's recycling system), specifically autophagosomes and lysosomes. In an influenza vaccine trial, autophagy activity rose and fell with the expansion of vaccine-specific T cells. People whose T cells showed more uneven division, especially uneven inheritance of the autophagy marker LC3B, had stronger vaccine responses. In lab experiments, briefly exposing T cells to rapamycin improved memory cell survival and increased this unevenness. The work suggests that how T cells divide may help explain individual differences in vaccine immunity.

Detailed Summary

Durable vaccine protection depends on stem-like memory T cells that can self-renew for years. Immune aging and weak vaccine responses in older adults are major healthspan concerns, yet how a single activated T cell chooses between a short-lived effector fate and a long-lived memory fate has been unclear in humans. Studies in mice suggest asymmetric cell division (ACD), in which the two daughters inherit unequal cargo, plays a role. Autophagy, the cell's recycling pathway, is also needed for memory. This paper asks whether the two processes work together in human immunity.

The team isolated CD8+ T cells from healthy donors and activated them with anti-CD3, anti-CD28 and Fc–ICAM-1, which mimics the stable contact with an antigen-presenting cell. They imaged the first division at 48 to 52 hours using confocal microscopy and defined ACD as an asymmetry ratio above 0.2. Fc–ICAM-1 induced CD8 asymmetry that was absent without it, while DAPI-stained DNA stayed symmetric. Progeny from ICAM-stimulated cells had more memory-like CD62L+CD27+ cells, plus more CD62L+CCR7+, CD62L+TCF-1+ and CD62L+FOXO1+ cells.

First-division daughters were sorted into the 20% highest (CD8 hi) and lowest (CD8 lo) CD8 expressers. CD8 lo cells survived better under limited IL-15, whereas CD8 hi cells proliferated faster and showed higher protein synthesis. RNA sequencing of seven donors found 2,298 differentially expressed genes. CD8 hi cells up-regulated effector genes such as TBX21, GZMB and IL2RA. CD8 lo cells up-regulated memory genes such as CCR7, BCL2, BCL6 and EOMES, along with autophagy-regulation pathways.

LC3B (autophagosomes) and LAMP1 (lysosomes) were both asymmetrically inherited, correlating moderately with CD8 asymmetry (r = 0.38 and 0.25). CD8 lo progeny had higher autophagic flux at day 3, and chloroquine selectively reduced memory-like CD62L+CD27+ cells without affecting effector-like cells. The transcription factor TFEB rose with activation and in TEMRA cells but was not asymmetrically distributed, which points to inheritance of the organelles themselves rather than transcriptional control.

In the FLU005 influenza vaccine trial (ChAdOx1 prime, MVA boost, NCT01818362; n = 20 for the ex vivo assays), autophagic flux, TFEB, GLUT1 and CPT1A were higher in tetramer-positive, antigen-specific CD8+ T cells than in tetramer-negative cells. The difference in autophagic flux was largest at day 63, after the booster. According to the abstract, people with greater ACD capacity, especially greater LC3B asymmetry, had better T cell ELISpot responses. Transient rapamycin (an mTORC1 inhibitor) improved memory survival and ACD, measured by CD8 and LC3B inheritance.

Caveats: ACD was measured on in vitro activated cells, with confocal analyses from a few donors. CD8 asymmetry did not change significantly across vaccination timepoints, which the authors attribute to antigen-specific cells being a small fraction of all CD8+ T cells. The rapamycin findings are lab-based, so no clinical dosing recommendation follows.

Key Findings

  • Fc–ICAM-1 induced CD8 asymmetry (threshold >0.2) in first-division human CD8+ T cells, while DAPI stayed symmetric, and increased memory-like CD62L+CD27+ progeny after 7 days in IL-15.
  • CD8 lo daughters (lowest 20% of CD8) survived better under limited IL-15 (n = 11), while CD8 hi daughters proliferated faster and had higher protein synthesis.
  • RNA-seq of seven donors found 2,298 differentially expressed genes: effector genes (TBX21, GZMB, IL2RA) in CD8 hi cells and memory genes (CCR7, BCL2, BCL6, EOMES) in CD8 lo cells.
  • LC3B and LAMP1 were asymmetrically inherited in mitotic CD8+ T cells and correlated modestly with CD8 asymmetry (r = 0.38 and 0.25).
  • Chloroquine selectively reduced memory-like CD62L+CD27+ cells but not effector-like CD25+CD44+ cells, implicating autophagy in memory fate.
  • In the influenza vaccine trial (n = 20), autophagic flux was higher in antigen-specific Tet+ cells at all timepoints, most pronounced at day 63 after the booster; GLUT1 and CPT1A also rose in recall.
  • Per the abstract, individuals with higher ACD capacity, especially LC3B asymmetry, had better vaccine T cell responses, and transient rapamycin improved memory survival and ACD.

Methodology

The study combined in vitro experiments on CD8+ T cells from healthy donors with ex vivo analysis of samples from the FLU005 influenza vaccine trial (ChAdOx1 H3N2 NP+M1 prime on day 0, optional MVA boost on day 56; NCT01818362). ACD was quantified by confocal microscopy of mitotic pairs using an asymmetry ratio (P1−P2)/(P1+P2), with DAPI as the symmetric control. Daughter cells were sorted by CD8 level and assessed by flow cytometry (viability, proliferation, OPP translation assay, autophagic flux with bafilomycin) and RNA sequencing (seven donors). Trial samples (n = 20) were analyzed by spectral flow cytometry with influenza tetramers, and statistics included Mann-Whitney, Kruskal-Wallis, t tests and ANOVA with multiple-comparison corrections.

Study Limitations

ACD was measured in vitro after artificial activation, and confocal imaging relied on a small number of donors and mitotic pairs. CD8 asymmetry did not change significantly across vaccination timepoints, possibly because antigen-specific cells are a small fraction of all CD8+ T cells, and the trial cohort was small (n = 20) with associations rather than causal proof in humans. Conflict-of-interest disclosures were not included in the supplied text.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: